Company profile
Originalis B.V.
Track record on TED — European public procurement
8
contracts won
—
value not disclosed by buyers
10.5
avg. bidders it beats
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Ranibizumab, ATC S01LA04 für die Zeit 01.09.2024 - 31.08.2026
🇩🇪 Germany · Pharmaceutical products · Sep 24, 2026
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Triptorelin, ATC L02AE04 für die Zeit 01.09.2024 - 31.08.2026
🇩🇪 Germany · Pharmaceutical products · Sep 24, 2026
Germany – Pharmaceutical products – Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Tacrolimus, ATC L04AD02 für die Zeit 01.09.2024 - 31.08.2025 (zzgl. Verlängerungsoption 1x12 Monate)
🇩🇪 Germany · Pharmaceutical products · Sep 24, 2026
Who dominates Medical equipments, pharmaceuticals and personal care products in Netherlands
🔒 8 more competitors in this market
Create free account →Open tenders in Originalis's sectors — right now
Live from Netherlands, closing soonest first. Every one shows its price to win with Pro.
Gemeente De Fryske Marren · Medical aids · closes in 1 days · €13,500,000
Stichting Amsterdam UMC · Stretchers · closes in 2 days
Radboud Universitair Medisch Centrum/Radboudumc · Medical consumables · closes in 5 days · €620,000
Gemeente Leiden · Medical aids · closes in 5 days · €350,000
Winning-price intelligence
What it takes to WIN medical equipments, pharmaceuticals and personal care products contracts in Netherlands
The median winning price, the typical range and how many bidders you'll face — computed from real awarded contracts. Know the number before you bid.
Median winning price
Typical range (P25–P75)
Bidders you'll face
Who wins & how much
Full winner history · winning-price benchmarks · every competitor · cancel anytime.
Public procurement data from TED (Tenders Electronic Daily) — © European Union, ted.europa.eu.